Kinetics and seroprevalence of SARS-CoV-2 antibodies: a comparison of 3 different assays
Abstract Comparing seroprevalence and antibody kinetics in three different commercially available assays for SARS-CoV-2. Serostatus of COVID-19 patients was analyzed 5 months and 10 months after their infection, using three different assays: Diasorin LIAISON, Euroimmun, Abbott Diagnostics ARCHITECT....
Saved in:
Main Authors: | Elisabeth Kahre, Lukas Galow, Manja Unrath, Luise Haag, Judith Blankenburg, Alexander H. Dalpke, Christian Lück, Reinhard Berner, Jakob P. Armann |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/3ad06cb755d9481f99002db848a9c614 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Novel Assay to Measure Seroprevalence of Zika Virus in the Philippines
by: Cameron Adams, et al.
Published: (2021) -
Antibody Responses to SARS-CoV-2 Infection—Comparative Determination of Seroprevalence in Two High-Throughput Assays versus a Sensitive Spike Protein ELISA
by: Dinesh Mohanraj, et al.
Published: (2021) -
Accurate SARS-CoV-2 seroprevalence surveys require robust multi-antigen assays
by: Christos Fotis, et al.
Published: (2021) -
SARS-CoV-2 antibody seroprevalence and associated risk factors in an urban district in Cameroon
by: Kene Nwosu, et al.
Published: (2021) -
Estimated seroprevalence of SARS-CoV-2 antibodies among adults in Orange County, California
by: Tim A. Bruckner, et al.
Published: (2021)